Literature DB >> 3306406

A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning.

C Guerin-Marchand, P Druilhe, B Galey, A Londono, J Patarapotikul, R L Beaudoin, C Dubeaux, A Tartar, O Mercereau-Puijalon, G Langsley.   

Abstract

The liver phase of development of malaria parasites has been studied only recently and remains poorly understood compared to the other stages such as sporozoïtes, merozoïtes and gametes. Access to liver forms of Plasmodium falciparum has been improved by the development of in vivo and in vitro propagation methods, but the yield of mature schizonts remains limited and does not allow a detailed antigenic analysis. To date, only immunofluorescence assays (IFA) have permitted a description of a species and liver-stage-specific antigen(s) (LSA; ref. 3). Monospecific antibodies to these antigens have not been obtained due either to difficulty in immunizing mice (against LSA), or to poor stability of human monoclonal antibodies. Therefore, as a means of characterizing the LSA, we used an alternative immunological approach to identify clones of the corresponding LSA genes. We describe here the isolation of a DNA sequence coding for a P. falciparum liver-stage-specific antigen composed of repeats of 17 amino-acids, which is immunogenic in man.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3306406     DOI: 10.1038/329164a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  55 in total

1.  Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.

Authors:  M B Joshi; A A Gam; R A Boykins; S Kumar; J Sacci; S L Hoffman; H L Nakhasi; R T Kenney
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  How to select Plasmodium falciparum pre-erythrocytic antigens in an expression library without defined probe.

Authors:  C Marchand; P Druilhe
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

3.  Usefulness of the recombinant liver stage antigen-3 for an early serodiagnosis of Plasmodium falciparum infection.

Authors:  Hyeong-Woo Lee; Sung-Ung Moon; Hye-Sun Ryu; Yeon-Joo Kim; Shin-Hyeong Cho; Gyung-Tae Chung; Khin Lin; Byoung-Kuk Na; Yoon Kong; Kyung-Suk Chung; Tong-Soo Kim
Journal:  Korean J Parasitol       Date:  2006-03       Impact factor: 1.341

4.  Survival and antigenic profile of irradiated malarial sporozoites in infected liver cells.

Authors:  A Suhrbier; L A Winger; E Castellano; R E Sinden
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

5.  Immunogenicity of four Plasmodium falciparum preerythrocytic antigens in Aotus lemurinus monkeys.

Authors:  B L Perlaza; M Arévalo-Herrera; K Brahimi; G Quintero; J C Palomino; H Gras-Masse; A Tartar; P Druilhe; S Herrera
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

Review 6.  Hepatic phase of malaria: a crucial role as "go-between" with other stages.

Authors:  D Mazier; J Goma; S Pied; L Renia; A Nussler; F Miltgen; D Mattei; G Grau
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

Review 7.  Class I HLA-restricted cytotoxic T lymphocyte responses against malaria--elucidation on the basis of HLA peptide binding motifs.

Authors:  D L Doolan; B Wizel; S L Hoffman
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

8.  Transposon mutagenesis reinforces the correlation between Mycoplasma pneumoniae cytoskeletal protein HMW2 and cytadherence.

Authors:  D C Krause; T Proft; C T Hedreyda; H Hilbert; H Plagens; R Herrmann
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

9.  Liver stage antigen 3 isolated from a cDNA library of Plasmodium falciparum erythrocytic stages.

Authors:  Eva M Moyano; Luis Miguel González; Susana Arahuetes; Agustín Benito
Journal:  Parasitol Res       Date:  2007-09-09       Impact factor: 2.289

10.  Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum.

Authors:  Alyssa E Barry; Lee Schultz; Caroline O Buckee; John C Reeder
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.